什么影响了降解剂-抗体结合剂 (DAC) 的活性?
Yaolin Guo1, Xiaoxue Li2, Yang Xie3
1Department of Respiratory and Critical Care Medicine, Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China; Frontiers Medical Center, Tianfu Jincheng Laboratory, Chengdu, 610212, Sichuan, China.
降解剂-抗体结合物 (DACs) 通过将抗体向与PROTACs相结合,增强向蛋白质降解 (TPD). DACs提高了选择性,并克服了潜在的癌症治疗的 PROTAC 局限性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 使用向蛋白质分解的嵌合体 (PROTACs) 的向蛋白质降解 (TPD) 显示出癌症治疗的前景,向以前无法治疗的蛋白质并克服耐药性.
- 由于大小,PROTACs面临诸多挑战,包括细胞选择性差,膜透性有限以及目标外毒性.
- 降解剂-抗体结合物 (DACs) 成为一种解决方案,利用抗体向和内部化来更有效地提供PROTACs.
研究的目的:
- 阐明DAC与传统抗体药物联合体 (ADC) 之间的特征和区别.
- 强调DACs在促进PROTAC交付和提高TPD疗效方面的重要性.
- 探索各种组件对DAC活动的影响,并指导未来DAC设计.
主要方法:
- 对DAC和ADC进行比较分析.
- 关于PROTAC技术和抗体结合策略的文献综述.
- 检查影响DAC性能的关键组件:抗体标,药物抗体比 (DAR),链接剂,PROTAC标,PROTAC结合和E3酶连接体.
主要成果:
- DACs利用抗体特异性来针对性地提供蛋白质降解剂.
- 分析突出了关键的设计元素,包括目标选择,DAR,链接器化学和E3酶参与.
- 研究了各种目标对DAC的适用性,以优化治疗策略.
结论:
- DAC提供了一种有希望的方法来克服传统 PROTAC 的局限性,提高选择性和交付性.
- 仔细考虑抗体和PROTAC组件对于有效的DAC设计至关重要.
- DACs代表了针对治疗应用的向蛋白质降解的重大进展.
更多相关视频
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
相关概念视频
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in...
Phase II Conjugation Reactions: Overview
